1. Home
  2. FLGT vs EMD Comparison

FLGT vs EMD Comparison

Compare FLGT & EMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • EMD
  • Stock Information
  • Founded
  • FLGT 2011
  • EMD 2003
  • Country
  • FLGT United States
  • EMD United States
  • Employees
  • FLGT N/A
  • EMD N/A
  • Industry
  • FLGT Medical Specialities
  • EMD Finance/Investors Services
  • Sector
  • FLGT Health Care
  • EMD Finance
  • Exchange
  • FLGT Nasdaq
  • EMD Nasdaq
  • Market Cap
  • FLGT 587.3M
  • EMD 604.6M
  • IPO Year
  • FLGT 2016
  • EMD N/A
  • Fundamental
  • Price
  • FLGT $21.93
  • EMD $10.28
  • Analyst Decision
  • FLGT Buy
  • EMD
  • Analyst Count
  • FLGT 3
  • EMD 0
  • Target Price
  • FLGT $25.33
  • EMD N/A
  • AVG Volume (30 Days)
  • FLGT 298.2K
  • EMD 248.5K
  • Earning Date
  • FLGT 08-01-2025
  • EMD 01-01-0001
  • Dividend Yield
  • FLGT N/A
  • EMD 10.25%
  • EPS Growth
  • FLGT N/A
  • EMD N/A
  • EPS
  • FLGT N/A
  • EMD N/A
  • Revenue
  • FLGT $303,223,000.00
  • EMD N/A
  • Revenue This Year
  • FLGT $15.19
  • EMD N/A
  • Revenue Next Year
  • FLGT $10.58
  • EMD N/A
  • P/E Ratio
  • FLGT N/A
  • EMD N/A
  • Revenue Growth
  • FLGT 4.31
  • EMD N/A
  • 52 Week Low
  • FLGT $14.57
  • EMD $7.85
  • 52 Week High
  • FLGT $23.56
  • EMD $9.55
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 68.17
  • EMD 53.45
  • Support Level
  • FLGT $21.27
  • EMD $10.20
  • Resistance Level
  • FLGT $21.77
  • EMD $10.30
  • Average True Range (ATR)
  • FLGT 0.58
  • EMD 0.07
  • MACD
  • FLGT 0.05
  • EMD -0.02
  • Stochastic Oscillator
  • FLGT 94.59
  • EMD 32.29

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About EMD Western Asset Emerging Markets Debt Fund Inc

Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management, and long term investment company. The primary investment objective of the company is to seek high current income and the secondary objective is to seek capital appreciation.

Share on Social Networks: